Table 2.

Details of women who received treatment related to abnormal menstrual bleeding within routine clinical care

ParameterWomen with AUB (n = 65)
Treatment related to AUB 21 (32%) 
Medical treatment  
Red blood cell transfusion 
Intravenous iron infusion 
Oral iron supplements 
Reduced dose of anticoagulant 
Temporary stop of anticoagulant 
Tranexamic acid 
Oral contraceptives started or intensified 
IUD insertion  
Implanon insertion 
Surgical treatment  
Hysterectomy 
Polypectomy  
ParameterWomen with AUB (n = 65)
Treatment related to AUB 21 (32%) 
Medical treatment  
Red blood cell transfusion 
Intravenous iron infusion 
Oral iron supplements 
Reduced dose of anticoagulant 
Temporary stop of anticoagulant 
Tranexamic acid 
Oral contraceptives started or intensified 
IUD insertion  
Implanon insertion 
Surgical treatment  
Hysterectomy 
Polypectomy  

Women could have undergone multiple medical and/or surgical treatments. AUB was defined according to at least one of the 3 definitions for AUB at at least one time during follow-up.

IUD, intrauterine device.

Hormone (progesterone)–containing IUD in 3 women; copper IUD in 2 women.

Planned treatment.

Close Modal

or Create an Account

Close Modal
Close Modal